Evidence map›Paper›PMID 38464414›Full record

ArticleJournal of translational autoimmunity2024

The effects of omega-3 fatty acids supplementation on hemoglobin, hematocrit, and platelet levels of patients with ESRD condition undergoing dialysis.

Zahra Mahmoudi, Zahra Roumi, Seyed Ali Askarpour, Zahra Mousavi, Hanieh Shafaei, Neda Valisoltani, Mahsa Shapouri, Seyed Reza Mirshafaei, Pouya Mirzaee, Khadijeh Abbasi Mobarakeh and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational autoimmunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zahra MahmoudiDepartment of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Zahra RoumiDepartment of Nutrition, Electronic Health and Statistics Surveillance Research Center, Science and Research Branch. Islamic Azad University, Tehran, Iran.
Seyed Ali AskarpourDivision of Food Safety and Hygiene, Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Zahra MousaviSchool of Nursing and Midwifery Shahed University, Tehran, Iran.
Hanieh ShafaeiDepartment of Nursing, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
Neda ValisoltaniDepartment of Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Mahsa ShapouriShahid Beheshti University of Medical Sciences, Tehran, Iran.
Seyed Reza MirshafaeiDepartment of applied mathematics, Roudsar and Amlash branch, Islamic Azad University, Roudsar, Iran.
Pouya MirzaeeDepartment of Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Khadijeh Abbasi MobarakehDepartment of Community Nutrition, Nutrition and Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Elahe Taghavi SufianiDepartment of Nursing, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
Zeinab Motiee BijarpasiDepartment of Nursing, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
Zeynab MotieiDepartment of Nursing, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
Masoud KhosraviUrology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Saeid DoaeiDepartment of Community Nutrition, School of Nutrition and Food Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maryam GholamalizadehCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Concomitant inflammation may boost the cardiovascular complications in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD). Omega-3 fatty acids may have certain health benefits in HD patients. The aim of this study was to investigate the effects of omega-3 fatty acids supplementation on hematocrit (HCT), hemoglobin (HB) level and platelet (PLT) counts of HD patients. Methods: A randomized controlled trial was conducted on HD patients at a private dialysis center in Rasht, Iran. Three omega-3 fatty acid supplement capsules (3 g/d) were administered daily for two months to patients in the intervention group (n = 55). The control group (n = 60) were given three placebo capsules containing medium chain triglyceride (MCT) oil, similar to the supplemental dose of the intervention group at the same period. Three parameters of HCT, HB and PLT were measured at baseline and after the intervention. Results: The PLT count decreased in the intervention group compared to the control group (173.38 ± 74.76 vs. 227.68 ± 86.58 10 Conclusion: Omega-3 supplementation in HD patients may decrease the risk of forming blood clots in the blood vessels. Further studies are warranted.

Indexed as

Chronic kidney diseaseHematocritHemodialysisHemoglobinOmega-3 fatty acidsPlatelet

Identifiers

PMID38464414
PMCPMC10924142

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.